Overview
Sencilia is pioneering next-generation NICU monitoring technology using advanced MEMS sensor architectures to address flow rate errors in pediatric and neonatal intensive care. The company's Rely-V® program focuses on detecting changes in low-flow infusions to prevent adverse drug events in fragile patients.
Funding & milestones
1 events found for Sencilia · 2026
Venture / equity1 source€2M
Reported amount €2,000,000
We are delighted that Sencilia has raised approximately €2 million, led by NV NOM, together with our existing investors Future Tech…
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Key people
In the news
- We are delighted that Sencilia has raised approximately €2 million, led by NV NOM, together with our existing investors Future Tech Ventures, imec.istart The Netherlands, RUG Ventures and Triade, all of whom have invested in us again, alongside private investors with backgrounds in the infusion industry. The financing is complemented by a Eureka Eurostars subsidy from the Netherlands Enterprise Agency (RVO) and an innovation loan from Rabobank. With this funding, we will advance Rely-V® toward production, generate further
- We are delighted that Sencilia has raised approximately €2 million, led by NV NOM, together with our existing investors Future Tech Ventures, imec.istart The Netherlands, RUG Ventures and Triade, all of whom have invested in us again, alongside private investors with backgrounds in the infusion industry. The financing is complemented by a Eureka Eurostars subsidy from the Netherlands Enterprise Agency (RVO) and an innovation loan from Rabobank. With this funding, we will advance Rely-V® toward production, generate further
- A big milestone in the journey of Sencilia, a start-up founded in 2021, which has now raised approximately €2 million! Sencilia originated from the bioinspired research conducted at our Bioinspired MEMS and Biomedical Devices (BMBD) Research Group at the Engineering and Technology Institute Groningen (ENTEG), University of Groningen. It is truly rewarding to see how fundamental research can evolve into an entrepreneurial venture with the potential to make a real-world impact. Congratulations to Amar Kamat and everyone involved in
- 𝐒𝐞𝐧𝐜𝐢𝐥𝐢𝐚 𝐫𝐚𝐢𝐬𝐞𝐬 €𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐨 𝐚𝐝𝐯𝐚𝐧𝐜𝐞 𝐬𝐚𝐟𝐞𝐫 𝐈𝐕 𝐦𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐟𝐨𝐫 𝐯𝐮𝐥𝐧𝐞𝐫𝐚𝐛𝐥𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 Groningen-based medtech and deeptech start-up Sencilia has secured approximately €2 million to further develop its Rely-V® sensor technology. The round consists of an equity investment from NOM, Future Tech Ventures, imec.istart, RUG Ventures, Triade and private investors, complemented by a Eureka Eurostars subsidy and an innovation loan from Rabobank.
- Congratulations to the Top 12 Health Techpreneurs of 2026 We are excited to reveal the finalists of the 18th Healthcare Innovation World Cup®, who will be presenting their solutions at MEDICA. With over 300 submissions from 60+ countries, these exceptional innovators made it to the top. ✨ Meet the Top 12 innovators, including: Allow Motion, Virtuoptica, Dotplot, Sencilia B.V., Kluba Medical GmbH, dotLumen, BlueAid Innovations Corp, MiWEndo Solutions, ROPHAI, CorPatch, Soterya, Inc., Zura Health More info here:
- Your pump says 1 mL/hr. Is that what the baby is getting?" The Sencilia booth was buzzing all week in West Palm Beach at #NANN2026! Our team crossed the Atlantic to connect directly with the neonatal nurses and clinical leaders who understand the critical stakes of low-flow IV infusion accuracy better than anyone else. Sencilia's mission is to bring continuous, non-contact infusion flow measurement to the NICU to support those on the front lines of neonatal care, wherever they are. Over the course of the conference, we gave live,
- Yesterday’s MIXER community event came with a proper imec.istart Awards Show, celebrating the startups that raised the bar this year. Here are the 2026 winners… 🥁 🏆 Booming Team Award - Payflip Fastest-growing team. Nominees: VEOWARE SPACE, Cuez, nxgsat 🏆 World Domination Award - VEOWARE SPACE For the startup taking on the world and winning. Nominees: Go Vocal, Cuez 🏆 Impact Catalyst Award - ReVision Implant For real, measurable impact on people, planet or society. Nominees: Puray, Sencilia 🏆 Pay It Forward Award - Aloïs Echard
- We're excited to share the publication of our nationwide nurse focus group study on infusion monitoring in neonatal intensive care, in the Journal of Neonatal Nursing (JNN)! One message came through loud and clear: when delivering medication at ultra-low flow rates, nurses often have limited visibility into whether medication is actually reaching the patient. Hearing this challenge echoed in nurses' firsthand accounts across multiple Dutch NICUs reinforces why we founded Sencilia: to bring more confidence and safety to infusion
Backers
Something wrong or missing? Send an update. Fixed within 24 hours.